Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 463
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Drug Discovery 104
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 90
Clinical Trials 90
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 60
Diabetes Drugs 53
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,373 Results (Page 59 of 119)
- Relevance
  Sort by

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1818EUR$2,000USD£1,568GBP

Anti-infective Vaccines Market Report 2023-2033

 Report
September 2023
303 Pages
Global

From

€4741EUR$5,398USD£3,950GBP

LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report

 Report
April 2025
190 Pages
Global

From

€2181EUR$2,400USD£1,881GBP

B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7226EUR$7,950USD£6,232GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
June 2026
385 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cervical Spondylosis Treatment Market - Global Strategic Business Report

 Report
June 2026
374 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Andersen-Tawil Syndrome (ATS) Market - Global Strategic Business Report

 Report
June 2026
276 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Rheumatology Therapeutics - Global Strategic Business Report

 Report
June 2026
196 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Dupuytren's Disease - Global Strategic Business Report

 Report
June 2026
369 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Skeletal Dysplasia Market - Global Strategic Business Report

 Report
June 2026
378 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Psoriatic Arthritis Treatment - Global Strategic Business Report

 Report
June 2026
452 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Sciatica Treatment Market - Global Strategic Business Report

 Report
June 2026
380 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Industry Snapshots: US Pharmaceuticals

 Newsletter
June 2026
50 Pages
United States

From

€218EUR$240USD£188GBP

Industry Snapshots: UK Pharmaceuticals

 Newsletter
June 2026
50 Pages
United Kingdom

From

€218EUR$240USD£188GBP

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
204 Pages
Global

From

€1818EUR$2,000USD£1,568GBP

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
94 Pages
Global

From

€1818EUR$2,000USD£1,568GBP

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
195 Pages
Global

From

€1818EUR$2,000USD£1,568GBP

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-Users and Key Geographical Regions

 Report
December 2025
343 Pages
Global

From

€4362EUR$4,799USD£3,762GBP

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
71 Pages
North America

From

€1363EUR$1,500USD£1,176GBP

Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Europe

From

€1363EUR$1,500USD£1,176GBP

2,373 Results (Page 59 of 119)
- 1
- 57
- 58
- 59
- 60
- 61

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.